Gasoline RBOB (RB September 2025)/ XFTTRBNYMETH / NYMEX ETH
RB4/22/2025 2:01:00 AM | Chg. +0.0081 | Bid2:57:05 AM | Ask2:57:05 AM | Open | High | Low | Previous Close |
---|---|---|---|---|---|---|---|
1.9921USD | +0.41% | 1.9908 | 1.9921 | 1.9874 | 1.9921 | 1.9874 | 1.9840 |
GlobeNewswire
4/15
Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targe...
GlobeNewswire
4/1
REPEAT -- Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164...
GlobeNewswire
3/31
Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164™, an ROR-...
GlobeNewswire
2/24
Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the...
GlobeNewswire
2/19
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate
GlobeNewswire
2/18
Brunswick Exploration Announces 2025 Exploration Plans for Greenland and Stakes Additional Ground Ne...
GlobeNewswire
2/18
AMERICAN SALARS ACQUIRES 18,083 HECTARE BRAZIL HARDROCK LCT PEGMATITE PROPERTY WITH RECENT SAMPLING ...
GlobeNewswire
1/31
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
GlobeNewswire
1/30
Axsome Therapeutics Announces FDA Approval of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Tr...
GlobeNewswire
8/22/2024
Regenx Tech to Present at the Clean Energy Metals Virtual Investor Conference August 29th
GlobeNewswire
8/14/2024
Toll Brothers City Living and Sculptor Real Estate Announce Construction is Complete at 151 Bay Stre...